3 Blue-Chip Stocks Trading at a Valuation Gap

Like
Comment
Favorite

3 Blue-Chip Stocks Trading at a Valuation Gap

InvestorPlace2023-07-20

These are the undervalued blue-chip stocks for high total returns in the next 24 months.AT&T (T): Big investment in wireline and wireless services will yield results as 5G adoption accelerates.Pfizer ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2352043949?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-07-20 20:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2352043949","market":"sg","top_or_hot":-1,"title":"3 Blue-Chip Stocks Trading at a Valuation Gap","media":"InvestorPlace","content":"<div>\n<p>These are the undervalued blue-chip stocks for high total returns in the next 24 months.AT&T (T): Big investment in wireline and wireless services will yield results as 5G adoption accelerates.Pfizer ...</p>\n\n<a href=\"https://investorplace.com/2023/07/3-blue-chip-stocks-trading-at-a-valuation-gap/\">Source Link</a>\n\n</div>\n","source":"investorplace_stock_picks","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Blue-Chip Stocks Trading at a Valuation Gap</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Blue-Chip Stocks Trading at a Valuation Gap\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-20 20:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2023/07/3-blue-chip-stocks-trading-at-a-valuation-gap/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>These are the undervalued blue-chip stocks for high total returns in the next 24 months.AT&T (T): Big investment in wireline and wireless services will yield results as 5G adoption accelerates.Pfizer ...</p>\n\n<a href=\"https://investorplace.com/2023/07/3-blue-chip-stocks-trading-at-a-valuation-gap/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4548","symbol_name":"巴美列捷福持仓","start_time":0,"source_url":"https://investorplace.com/2023/07/3-blue-chip-stocks-trading-at-a-valuation-gap/","article_id":"2352043949","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2352043949","pubTimestamp":1689857070,"columns":[],"sourceInfo":{"source_id":"investorplace_stock_picks","name":"InvestorPlace stock picks"},"weMediaInfo":null,"summary":"These are the undervalued blue-chip stocks to buy for high total returns in the next two years","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4548":"巴美列捷福持仓","SG9999001176.USD":"United Global Healthcare Acc USD","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","IE00B1B80R65.USD":"柏瑞拉丁美洲股票A","LU1023059493.AUD":"Blackrock World Mining A2 AUD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0449509016.USD":"HSBC GIF BRIC EQUITY \"AC\" (USD) ACC","LU0214875030.USD":"HSBC GIF BRIC EQUITY \"M2C\" (USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK4006":"钢铁","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0256859116.SGD":"施罗德拉丁美洲A Acc SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","PFE":"辉瑞","BK4585":"ETF&股票定投概念","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0075056555.USD":"贝莱德世界矿业基金A2","LU0106259046.USD":"施罗德拉丁美洲基金","BK4507":"流媒体概念","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4007":"制药","LU0572108347.SGD":"Blackrock Latin American A2 SGD-H","SG9999002232.USD":"Allianz Global High Payout USD","LU0234572021.USD":"高盛美国核心股票组合Acc","T":"美国电话电报","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0058720904.USD":"联博国际健康护理基金A","LU0330918003.SGD":"Blackrock World Mining A2 SGD-H","BK4588":"碎股","BK4550":"红杉资本持仓","LU0072463663.USD":"Blackrock Latin American A2 USD","BK4115":"综合电信业务","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK7095":"多种金属与采矿","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4094":"服装零售","LU0122379950.USD":"贝莱德世界健康科学A2","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","VALE":"淡水河谷","BK4581":"高盛持仓","LU0149725797.USD":"汇丰美国股市经济规模基金","PFE.AU":"PANTERA MINERALS LTD"},"translate_title":"3只蓝筹股在估值缺口交易","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VALE":1,"GPS":1,"PFE":1,"PFE.AU":1,"T":1},"content_text":"These are the undervalued blue-chip stocks for high total returns in the next 24 months.AT&T (T): Big investment in wireline and wireless services will yield results as 5G adoption accelerates.Pfizer (PFE): New molecular entities and acquisitions setting the stage for the next phase of growth.Vale (VALE): Strong fundamentals will support portfolio diversification. \n\n\n\n \n\nSource: Epic Cure / Shutterstock\n\n\n\nAs the S&P 500 index trends higher, spotting undervalued blue-chip stocks is relatively challenging. A dovish fed and a declining possibility of a recession have supported an improvement in market sentiment. I believe the markets will likely remain in an uptrend, with global economic activity expected to improve further in 2024.\nOf course, a meaningful market rally for year-to-date does not imply that stocks are overvalued. On the contrary, several stocks trade at a valuation gap. At some point in time, these fundamentally strong blue-chip stocks will rally.\nI would therefore accumulate these undervalued stocks with an initial time horizon of 12 to 24 months. Considering the valuation gap, these stocks will likely beat index returns during the time horizon. Let’s discuss the reasons to be bullish on these stocks.\n\n\n\n\n\n\nAT&T (T)\nSource: Gorodenkoff/Shutterstock.com\nAT&T (NYSE:T) stock has underperformed with a deep correction of 28% for year-to-date. However, I believe the stock is significantly oversold at a forward price-earnings ratio of 5.5. The stock also offers an attractive dividend yield of 8.2%.\nI believe that the company’s results have been encouraging, and the stock reversal is likely to be sharp. For Q1 2023, AT&T reported steady revenue and EBITDA growth from the mobility segment. Importantly, the average revenue per user trended higher by 2% yearly. With growing 5G adoption, I expect the ARPU trend to remain positive, supporting cash flow growth.\nIt’s worth noting that AT&T is a deleveraging story. Last year, the company reduced net debt by $24 billion. I expect deleveraging and improvement in credit metrics to continue. Earlier this year, it was reported that AT&T is looking to sell its cybersecurity business. That’s an impending catalyst for T stock upside as it’s likely to support accelerated deleveraging.\n\n\n\n\n\n\nPfizer (PFE)\nSource: aslysun / Shutterstock.com\nPfizer (NYSE:PFE) stock is another grossly undervalued blue-chip name that’s worth considering for healthy returns. A dividend yield of 4.53% is also attractive, and I expect steady growth in the coming years.\nUncertainties related to growth after the pandemic is one reason for PFE stock correction. The impact of drugs going off-patent is another reason the markets are nervous. However, I believe these factors are discounted with PFE stock trading at a forward price-earnings ratio of 10.9.\nTo boost sales, Pfizer has been investing aggressively in research and development. With a deep pipeline, the company expects $20 billion in incremental revenue from new molecular entities by 2030. Further, new business developments will translate into $25 billion in incremental revenue by 2030. As the company builds a strong foundation for the next phase of innovation and growth, PFE stock is a buy-and-hold.\n\n\n\n\n\n\nVale (VALE)\nSource: Spyro the Dragon / Shutterstock.com\nAmong commodity blue-chip stocks, Vale (NYSE:VALE) is massively undervalued. The 2.87% dividend yields stock trades at a forward price-earnings ratio 6.1. I would not be surprised if VALE stock doubled in the next 24 months.\nFrom a macroeconomic perspective, the International Monetary Fund expects global GDP growth to accelerate in 2024 as compared to 2023. Further, a potentially weaker dollar is likely to be positive for commodities. The worst in terms of price realization might therefore be over for Vale.\nI also like the point that Vale is looking at diversification. With high financial flexibility, the company’s investment in copper and nickel mining will likely accelerate. Reshaping the portfolio towards metals likely to benefit from the energy transition will support Vale’s growth.\nFrom a financial perspective, Vale reported an adjusted EBITDA of $3.7 billion for Q1 2023. This implies an annual EBITDA potential of $15 billion. Internal cash flows are likely to fund investments and dividends.\nOn the date of publication, Faisal Humayun did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.\n\nFaisal Humayun is a senior research analyst with 12 years of industry experience in the field of credit research, equity research and financial modeling. Faisal has authored over 1,500 stock specific articles with focus on the technology, energy and commodities sector.\n\n\nUndervalued Stocks\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nSubmit\n\n\n\n\n\n\n\nArticle printed from InvestorPlace Media, https://investorplace.com/2023/07/3-blue-chip-stocks-trading-at-a-valuation-gap/.\n©2023 InvestorPlace Media, LLC\n\n\n\n\nSponsored Headlines","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}